logo
09:19 Jun 24

Nectar Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
11.40
-0.11 (-0.96%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Nectar Lifesciences Ltd. Financials

Nectar Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
11.40
-0.11 (-0.96%)
09:19 Jun 24
Quality
image/svg+xml

39/100
Medium Financial Strength

Valuation
image/svg+xml

28/100
Expensive Valuation

Technical

28/100
Technically Bearish

Strength

4

Weakness

11

Opportunity

1

Threats

0

-50.29 %

ROE %

-47.11 %

ROA %

-13.06

EPS

29.97

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
1668.83 1523.67 1684.09 1669.97 0
Operating Expenses +
1510.29 1470.66 1532.53 1699.53 60.7
Raw Material
1207.32 1200.84 1242.45 1250.72 0
Increase Decrease in Cost
15.81 -41.55 -40.21 117.29 0
Other Manufacturing Expense
146.37 172.14 184.64 163.22 0
Employee Cost
74.55 77.78 84.67 96.48 1.91
Miscellaneous Expenses
67.12 61.45 60.98 71.82 58.79
Operating Profit
158.54 53.01 151.56 -29.56 -60.7
Other Income
11.32 43.18 14.58 4.99 9.29
Depreciation
56.97 59.12 60.72 62.39 0.34
Interest
78.81 79.49 87.14 74.58 36.13
Profit before tax and exceptio..
34.08 -42.42 18.27 -161.53 -87.88
Exceptional Items
0 0 0 0 0
PBT
34.08 -42.42 18.27 -161.53 -87.88
Provision for Taxation
9.03 -18.24 13.27 -47.85 -30.53
Net Profit
25.05 -24.18 5 -113.68 -292.89
NET Profit after MI
25.05 -24.18 5 -113.68 -292.89
EPS
1.12 -1.08 0.22 -5.07 -13.4
Operating Profit Margin (%)
9.5 3.48 9 -1.77 0
Net Profit Margin (%)
1.5 -1.59 0.3 -6.81 0

Nectar Lifesciences Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 51.80 44.90 44.90 44.50 44.50 44.50
FII 0.60 0.50 0.60 0.80 1.60 0.70
Public 4.00 5.90 0.10 0.20 0.20 0.10
Others 43.60 48.70 54.40 54.50 53.70 54.70
Shareholder Shares Holding %
Research 360 logo
Download Our App On: